RHY 1.22% 8.1¢ rhythm biosciences limited

I agree with your assessment of the long-term perspective, and...

  1. 706 Posts.
    lightbulb Created with Sketch. 638
    I agree with your assessment of the long-term perspective, and it's evident you have a keen understanding of the details. While the IPO strategy was effective initially, strategies require continuous iteration and sometimes running multiple commercialisation strategies is sound. My focus was on more recent history, emphasizing that attributing all failings to TGA's adoption of the IVDR and claiming it was beyond their control might not be entirely accurate. Given the significance of the EU and US markets, a proactive engagement with regulators, including the TGA, likely would have mitigated the failure and preserved shareholder equity. Despite this current circus, if the test continues to prove effective and meets regulators' standards, it remains innovative. Post-249D clearing the dead wood, the potential for a significant turnaround is exciting.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.001(1.22%)
Mkt cap ! $19.92M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $12.04K 147.3K

Buyers (Bids)

No. Vol. Price($)
1 7321 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 13376 1
View Market Depth
Last trade - 11.53am 07/05/2024 (20 minute delay) ?
Last
8.1¢
  Change
-0.001 ( 2.41 %)
Open High Low Volume
8.2¢ 8.2¢ 8.1¢ 31384
Last updated 11.53am 07/05/2024 ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.